# A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection

> **NCT00002177** · NA · COMPLETED · sponsor: **Bristol-Myers Squibb**

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Hydroxyurea
- **DRUG:** Nelfinavir mesylate
- **DRUG:** Stavudine
- **DRUG:** Didanosine

## Key facts

- **NCT ID:** NCT00002177
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-05
- **Primary completion:** 2000-03
- **Final completion:** 2000-03
- **Target enrollment:** — (—)
- **Last updated:** 2011-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002177, "A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00002177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*